Hillman Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$318K Sell
3,668
-71
-2% -$6.8K 0.22% 52
2025
Q4
$359K Sell
3,739
-9
-0.2% -$874 0.23% 50
2025
Q3
$357K Sell
3,748
-54
-1% -$4.96K 0.21% 47
2025
Q2
$331K Buy
3,802
+290
+8% +$24.6K 0.18% 47
2025
Q1
$316K Buy
+3,512
New +$314K 0.16% 47
2024
Q4
Sell
-3,207
Closed -$289K 57
2024
Q3
$289K Buy
3,207
+45
+1% +$3.79K 0.1% 47
2024
Q2
$249K Sell
3,162
-331
-9% -$27.1K 0.09% 49
2024
Q1
$304K Buy
+3,493
New +$298K 0.1% 48
2023
Q4
Sell
-3,357
Closed -$263K 55
2023
Q3
$263K Sell
3,357
-2,671
-44% -$224K 0.1% 48
2023
Q2
$531K Sell
6,028
-206
-3% -$17.7K 0.19% 45
2023
Q1
$503K Buy
6,234
+990
+19% +$80.7K 0.19% 44
2022
Q4
$408K Sell
5,244
-1,991
-28% -$161K 0.16% 48
2022
Q3
$584K Buy
7,235
+432
+6% +$38.8K 0.24% 44
2022
Q2
$611K Buy
6,803
+420
+7% +$42.6K 0.22% 39
2022
Q1
$708K Buy
6,383
+761
+14% +$80.4K 0.22% 39
2021
Q4
$582K Sell
5,622
-213
-4% -$24.7K 0.2% 39
2021
Q3
$731K Buy
5,835
+2,479
+74% +$321K 0.26% 35
2021
Q2
$417K Buy
3,356
+22
+0.7% +$2.76K 0.16% 36
2021
Q1
$394K Sell
3,334
-11
-0.3% -$1.29K 0.17% 35
2020
Q4
$392K Buy
3,345
+230
+7% +$25.3K 0.21% 36
2020
Q3
$324K Sell
3,115
-46
-1% -$4.62K 0.23% 35
2020
Q2
$290K Buy
3,161
+97
+3% +$9.3K 0.21% 36
2020
Q1
$276K Sell
3,064
-23,295
-88% -$2.48M 0.26% 34
2019
Q4
$2.99M Buy
+26,359
New +$2.89M 2.12% 28

Other funds holding MDT

Hillman Capital Management's MDT Position: Q1 2026 in Review

Hillman Capital Management reduced its Medtronic (MDT) stake by 1.9% in Q1 2026, selling an estimated $6.8K and leaving 3,668 shares worth $318K. The position accounts for 0.22% of the portfolio, ranked #52.

Hillman Capital Management first reported a position in MDT in Q4 2019 and has held it in 24 quarters since. The position peaked at $2.99M in Q4 2019. 2,240 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Hillman Capital Management held 3,668 shares of Medtronic worth $318K as of Q1 2026.
  • Hillman Capital Management sold 71 Medtronic shares in Q1 2026, an estimated $6.8K.
  • Medtronic made up 0.22% of Hillman Capital Management's portfolio in Q1 2026, its #52 holding.
  • Hillman Capital Management first reported a position in Medtronic in Q4 2019 and has held it in 24 quarters since.
  • Hillman Capital Management's Medtronic position peaked at $2.99M in Q4 2019.
  • 2,240 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Hillman Capital Management's 13F filing for Q1 2026, filed 15 May 2026.